Related references
Note: Only part of the references are listed.Association Between NEDD4L Gene and Sodium Lithium Countertransport
Xiaojing Zheng et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Cardiovascular Pharmacogenomics of Adrenergic Receptor Signaling: Clinical Implications and Future Directions
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System-Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
Tadashi Konoshita
CURRENT HYPERTENSION REPORTS (2011)
Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study
Ervin R. Fox et al.
HUMAN MOLECULAR GENETICS (2011)
Association of Hypertension Drug Target Genes With Blood Pressure and Hypertension in 86 588 Individuals
Andrew D. Johnson et al.
HYPERTENSION (2011)
A functional variant of the NEDD4L gene is associated with beneficial treatment response with β-blockers and diuretics in hypertensive patients
Patrik Svensson-Farbom et al.
JOURNAL OF HYPERTENSION (2011)
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
Georg B. Ehret et al.
NATURE (2011)
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure
Louise V. Wain et al.
NATURE GENETICS (2011)
Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians
Norihiro Kato et al.
NATURE GENETICS (2011)
Pharmacogenetic Effect of the Stromelysin (MMP3) Polymorphism on Stroke Risk in Relation to Antihypertensive Treatment The Genetics of Hypertension Associated Treatment Study
Richard Sherva et al.
STROKE (2011)
Plasma Renin Activity Predicts Blood Pressure Responses to β-Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension
Stephen T. Turner et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Genetic Variation in the β2 Subunit of the Voltage-Gated Calcium Channel and Pharmacogenetic Association With Adverse Cardiovascular Outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES)
Yuxin Niu et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
Jasper Jan Brugts et al.
EUROPEAN HEART JOURNAL (2010)
Human Nedd4L rs4149601 G Allele Generates Evolutionary New Isoform I With C2 Domain
Tomoaki Ishigami et al.
HYPERTENSION (2010)
Antihypertensive drug therapy and blood pressure control in men and women: an international perspective
M. Thoenes et al.
JOURNAL OF HUMAN HYPERTENSION (2010)
Common genetic variation of β1-and β2-adrenergic receptor and response to four classes of antihypertensive treatment
Timo Suonsyrja et al.
PHARMACOGENETICS AND GENOMICS (2010)
Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study
Julie A. Johnson et al.
AMERICAN HEART JOURNAL (2009)
A Functional Variant of NEDD4L Is Associated With Hypertension, Antihypertensive Response, and Orthostatic Hypotension
Fang Luo et al.
HYPERTENSION (2009)
Blood pressure control and physicians' therapeutic behavior in a very elderly Spanish hypertensive population
Gustavo C. Rodriguez-Roca et al.
HYPERTENSION RESEARCH (2009)
Genome-wide association study identifies eight loci associated with blood pressure
Christopher Newton-Cheh et al.
NATURE GENETICS (2009)
Genome-wide association study of blood pressure and hypertension
Daniel Levy et al.
NATURE GENETICS (2009)
beta 1- and beta 2-adrenergic receptor gene beta-blocker use and risk of myocardial infarction and stroke
Rozenn N. Lemaitre et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension
M. A. Pacanowski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Screening, treatment, and control of hypertension in US private physician offices, 2003-2004
Jun Ma et al.
HYPERTENSION (2008)
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic
Stephen T. Turner et al.
HYPERTENSION (2008)
Salt-sensitive hypertension and cardiac hypertrophy in mice deficient in the ubiquitin ligase Nedd4-2
Peijun P. Shi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Pharmacogenetics of β-blockers
Jaekyu Shin et al.
PHARMACOTHERAPY (2007)
Polymorphism in NEDD4L Is Associated with Increased Salt Sensitivity, Reduced Levels of P-renin and Increased Levels of Nt-proANP
Jonas Dahlberg et al.
PLOS ONE (2007)
Predictors of antihypertensive drug responses:: Initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study)
Tirno P. Hiltunen et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
β1-adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension
Jie Liu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Current status of antihypertensive prescription and associated blood pressure control in Japan
Hisao Mori et al.
HYPERTENSION RESEARCH (2006)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Association of NEDD4L ubiquitin ligase with essential hypertension
CJ Russo et al.
HYPERTENSION (2005)
Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade
F Filigheddu et al.
PHARMACOGENOMICS JOURNAL (2004)
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial
CJ Pepine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
β1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol
JA Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Share Paper
